Publications of A. Ullrich
All genres
Journal Article (154)
121.
Journal Article
41 (5), p. 470 - 470 (2004)
EphB4 signaling regulates vascular morphogenesis and permeability in adult neo-angiogenesis, both under pathological and physiological conditions. Journal of Vascular Research 122.
Journal Article
17 (15), pp. 338 - 340 (2004)
Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB Journal 123.
Journal Article
172, pp. 2578 - 2585 (2004)
Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha. Journal of Immunology 124.
Journal Article
250, pp. 49 - 60 (2004)
Detection of ERK1/2 kinase activities using affinity reagents. Methods in Molecular Biology 125.
Journal Article
31, pp. 1203 - 1208 (2003)
EGFR signal transactivation in cancer cells. Biochemical Society Transactions 126.
Journal Article
134 (5), pp. 772 - 782 (2003)
Pancreatic cancer growth is inhibited by blockade of VEGF-RII. Surgery 127.
Journal Article
7 (4), pp. 490 - 495 (2003)
Beyond Herceptin and Gleevec. Current Opinion in Chemical Biology 128.
Journal Article
384 (8), pp. 1215 - 1226 (2003)
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2. Biological Chemistry 129.
Journal Article
22 (10), pp. 2411 - 2421 (2003)
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO Journal 130.
Journal Article
278 (17), pp. 15435 - 15440 (2003)
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors. Journal of Biological Chemistry 131.
Journal Article
17 (4), pp. 534 - 549 (2003)
Protein tyrosine phosphatase PTP20 induces actin cytoskeleton reorganization by dephosphorylating p190 RhoGAP in rat ovarian granulosa cells stimulated with follicle-stimulating hormone. Molecular Endocrinology 132.
Journal Article
15 (3), pp. 319 - 326 (2003)
The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2. Cellular Signalling 133.
Journal Article
278 (6), pp. 3809 - 3815 (2003)
Dominant negative form of signal-regulatory protein-alpha (SIRP alpha/SHPS-1) inhibits tumor necrosis factor-mediated apoptosis by activation of NF-kappa B. Journal of Biological Chemistry 134.
Journal Article
4 (2), pp. 124 - 131 (2003)
Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nature Immunology 135.
Journal Article
279, pp. 10765 - 10775 (2003)
Mutual regulation of protein-tyrosine phosphatase 20 and protein-tyrosine kinase Tec activities by tyrosine phosphorylation and dephosphorylation. Journal of Biological Chemistry 136.
Journal Article
37 (1), pp. 89 - 101 (2003)
The cDNA microarray profiling of protein kinases and phosphatases: Molecular portrait of human prostate carcinomas. Molecular Biology (Mosk.) 137.
Journal Article
27 (2), pp. 155 - 162 (2003)
The antitumor effect of the somatostatin analogue TT-232 depends on the treatment regimen. Cancer Detection and Prevention 138.
Journal Article
102 (6), pp. 572 - 579 (2002)
Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. International Journal of Cancer 139.
Journal Article
277 (46), pp. 44164 - 44170 (2002)
Crystal structure of a C-terminal fragment of growth arrest- specific protein Gas6 - Receptor tyrosine kinase activation by laminin G-like domains. Journal of Biological Chemistry 140.
Journal Article
62 (21), pp. 6329 - 6336 (2002)
Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal Transactivation. Cancer Research